อ้างอิง ของ เวกเตอร์ไวรัส

  1. 1 2 Goff, SP; Berg, P (December 1976). "Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells". Cell. 9 (4 PT 2): 695–705. doi:10.1016/0092-8674(76)90133-1. PMID 189942. S2CID 41788896.
  2. "Transfection". US National Library of Medicine Medical Subject Headings (MeSH).
  3. "Transfection". Protocols and Applications Guide. Promega.
  4. "Xenotransplantation". World Health Organization.
  5. ↑ Beardsley, T (February 2000). "A tragic death clouds the future of an innovative treatment method". Scientific American.
  6. ↑ McDowell, N (2003-01-15). "New cancer case halts US gene therapy trials". New Scientist.
  7. ↑ Hacein-Bey-Abina, S; Hauer, J; Lim, A; Picard, C; Wang, GP; Berry, CC; และคณะ (July 2010). "Efficacy of gene therapy for X-linked severe combined immunodeficiency". The New England Journal of Medicine. 363 (4): 355–64. doi:10.1056/NEJMoa1000164. PMC 2957288. PMID 20660403.
  8. ↑ Sasmita, AO (April 2019). "Current viral-mediated gene transfer research for treatment of Alzheimer's disease". Biotechnology & Genetic Engineering Reviews. 35 (1): 26–45. doi:10.1080/02648725.2018.1523521. PMID 30317930. S2CID 52978228.
  9. ↑ "Glossary".
  10. ↑ Arashkia, A; Jalilvand, S; Mohajel, N; Afchangi, A; Azadmanesh, K; Salehi-Vaziri, M; และคณะ (2020). "Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects". Reviews in Medical Virology. n/a (n/a): e2183. doi:10.1002/rmv.2183. PMC 7646037 Check |pmc= value (help).
  11. ↑ "Exeter Fellow Dr Catherine Green leads the production of a potential COVID-19 vaccine in Oxford". Exeter College (ภาษาอังกฤษ). 2020-04-06. สืบค้นเมื่อ 2020-04-24.
  12. ↑ "AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19". www.astrazeneca.com (ภาษาอังกฤษ). สืบค้นเมื่อ 2020-11-27.
  13. ↑ "EPAR summary for the public: Oncept IL-2 (Feline interleukin-2 recombinant canary pox virus) [EMA/151380/2013 EMEA/V/C/002562]" (PDF). European Medical Agency. 2013.
  14. ↑ Cavazzana-Calvo, M; Hacein-Bey, S; de Saint Basile, G; Gross, F; Yvon, E; Nusbaum, P; และคณะ (April 2000). "Gene therapy of human severe combined immunodeficiency (SCID) -X1 disease". Science. 288 (5466): 669–72. Bibcode:2000Sci...288..669C. doi:10.1126/science.288.5466.669. PMID 10784449.
  15. ↑ Varmus, Harold; Coffin, John M.; Hughes, Stephen H., บ.ก. (1997). "Principles of Retroviral Vector Design". Retroviruses. Plainview, N.Y: Cold Spring Harbor Laboratory Press. ISBN 978-0-87969-571-2.
  16. ↑ Hacein-Bey-Abina, S; F, Le Deist; Carlier, F; Bouneaud, C; Hue, C; De Villartay, JP; และคณะ (April 2002). "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy". The New England Journal of Medicine. 346 (16): 1185–93. doi:10.1056/NEJMoa012616. PMID 11961146.
  17. ↑ Hacein-Bey-Abina, S; Von Kalle, C; Schmidt, M; McCormack, MP; Wulffraat, N; Leboulch, P; และคณะ (October 2003). "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1". Science. 302 (5644): 415–9. Bibcode:2003Sci...302..415H. doi:10.1126/science.1088547. PMID 14564000. S2CID 9100335.
  18. ↑ Marini, B; Kertesz-Farkas, A; Ali, H; Lucic, B; Lisek, K; Manganaro, L; และคณะ (May 2015). "Nuclear architecture dictates HIV-1 integration site selection". Nature. 521 (7551): 227–31. Bibcode:2015Natur.521..227M. doi:10.1038/nature14226. PMID 25731161. S2CID 974969.
  19. ↑ Cattoglio, C; Facchini, G; Sartori, D; Antonelli, A; Miccio, A; Cassani, B; และคณะ (September 2007). "Hot spots of retroviral integration in human CD34+ hematopoietic cells". Blood. 110 (6): 1770–8. doi:10.1182/blood-2007-01-068759. PMID 17507662.
  20. ↑ Montini, E; Cesana, D; Schmidt, M; Sanvito, F; Ponzoni, M; Bartholomae, C; และคณะ (June 2006). "Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration". Nature Biotechnology. 24 (6): 687–96. doi:10.1038/nbt1216. PMID 16732270. S2CID 8966580.
  21. ↑ Lidonnici, MR; Paleari, Y; Tiboni, F; Mandelli, G; Rossi, C; Vezzoli, M; และคณะ (December 2018). "Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia". Molecular Therapy. Methods & Clinical Development (ภาษาอังกฤษ). 11: 9–28. doi:10.1016/j.omtm.2018.09.001. PMC 6178212. PMID 30320151.
  22. ↑ Ramos-Kuri, M; Rapti, K; Mehel, H; Zhang, S; Dhandapany, PS; Liang, L; และคณะ (November 2015). "Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853 (11 Pt A): 2870–84. doi:10.1016/j.bbamcr.2015.08.006. PMC 4715892. PMID 26260012.
  23. ↑ "Adeno- associated virus vector integration". 2010. PMID 19649989. Cite journal requires |journal= (help)
  24. 1 2 Nussbaum, Robert L; McInnes, Roderick R; Willard, Huntington F (2015). Thompson & Thompson Genetics in Medicine. Canada: ELSEVIER. p. 278. ISBN 978-1-4377-0696-3.
  25. ↑ McCarty, DM; Monahan, PE; Samulski, RJ (August 2001). "Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis". Gene Therapy. 8 (16): 1248–54. doi:10.1038/sj.gt.3301514. PMID 11509958.
  26. ↑ Abrahamian, Peter; Hammond, Rosemarie W.; Hammond, John (2020-06-10). "Plant Virus-Derived Vectors: Applications in Agricultural and Medical Biotechnology". Annual Review of Virology. 7. doi:10.1146/annurev-virology-010720-054958. ISSN 2327-0578. PMID 32520661.
  27. ↑ Pasin, Fabio; Menzel, Wulf; Daròs, José-Antonio (June 2019). "Harnessed viruses in the age of metagenomics and synthetic biology: an update on infectious clone assembly and biotechnologies of plant viruses". Plant Biotechnology Journal. 17 (6): 1010–1026. doi:10.1111/pbi.13084. ISSN 1467-7652. PMC 6523588. PMID 30677208.
  28. ↑ Huang, S; Kamihira, M (2013). "Development of hybrid viral vectors for gene therapy". Biotechnology Advances. 31 (2): 208–23. doi:10.1016/j.biotechadv.2012.10.001. PMID 23070017.
  29. 1 2 Nayak, S; Herzog, RW (March 2010). "Progress and prospects: immune responses to viral vectors". Gene Therapy. 17 (3): 295–304. doi:10.1038/gt.2009.148. PMC 3044498. PMID 19907498.
  30. ↑ Zhou, HS; Liu, DP; Liang, CC (November 2004). "Challenges and strategies: the immune responses in gene therapy". Medicinal Research Reviews. 24 (6): 748–61. doi:10.1002/med.20009. PMID 15250039. S2CID 17622444.
  31. ↑ Crommelin, DJ; Sindelar, RD; Meibohm, B (2008). Pharmaceutical Biotechnology: Fundamentals and application. London: Taylor & Francis. ISBN 978-1420044379.
  32. ↑ Yang, ZY; Wyatt, LS; Kong, WP; Moodie, Z; Moss, B; Nabel, GJ (January 2003). "Overcoming immunity to a viral vaccine by DNA priming before vector boosting". Journal of Virology. 77 (1): 799–803. doi:10.1128/JVI.77.1.799-803.2003. PMC 140625. PMID 12477888.
  33. ↑ Pandey, A; Singh, N; Vemula, SV; Couëtil, L; Katz, JM; Donis, R; และคณะ (2012). Subbiah, Elankumaran (บ.ก.). "Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine". PLOS ONE. 7 (3): e33428. Bibcode:2012PLoSO...733428P. doi:10.1371/journal.pone.0033428. PMC 3303828. PMID 22432020.

ใกล้เคียง

เวกเตอร์ไวรัส เวกเตอร์ลักษณะเฉพาะ เวกเตอร์ เวกเตอร์สี่มิติ เวกเตอร์หนึ่งหน่วย เวกเตอร์พอยน์ติง เวกเตอร์อะดีโนไวรัส เวกเตอร์แนวฉาก เวกเตอร์ (โครงสร้างข้อมูล) เวกเตอร์ (แก้ความกำกวม)